Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum

Experimental Cell Research

Volumn 314, Issue 17, 2008, Pages 3221-3231

  Szczesna Skorupa, Elzbieta ^a   Kemper, Byron ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

BAP31; Calnexin; Cytochrome P450; Endoplasmic reticulum; ER associated degradation (ERAD); Intracellular trafficking; MG132; Proteasome; sec61

Indexed keywords

BAP31 PROTEIN; CALNEXIN; CHIMERIC PROTEIN; CYTOCHROME P450 2C2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; CYTOCHROME P450 REDUCTASE; GREEN FLUORESCENT PROTEIN; NOCODAZOLE; PROTEASOME; PROTEIN; SEC61 PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL SURFACE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

EID: 53049108739     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.08.003     Document Type: Article

References (63)

1. Murakami K., Mihara K., and Omura T. The transmembrane region of microsomal cytochrome P450 identified as the endoplasmic reticulum retention signal. J. Biochem. 116 (1994) 164-175
2. Szczesna-Skorupa E., Ahn K., Chen C.D., Doray B., and Kemper B. The cytoplasmic and N-terminal transmembrane domains of cytochrome P450 contain independent signals for retention in the endoplasmic reticulum. J. Biol. Chem. 270 (1995) 24327-24333
3. Szczesna-Skorupa E., Chen C.D., and Kemper B. Cytochromes P450 2C1/2 and P450 2E1 are retained in the endoplasmic reticulum membrane by different mechanisms. Arch. Biochem. Biophys. 374 (2000) 128-136
4. Homma K., Yoshida Y., and Nakano A. Evidence for recycling of cytochrome P450 sterol 14-demethylase from the cis-Golgi compartment to the endoplasmic reticulum (ER) upon saturation of the ER-retention mechanism. J. Biochem. 127 (2000) 747-754
5. Seliskar M., and Rozman D. Mammalian cytochromes P450-importance of tissue specificity. Biochim. Biophys. Acta. 1770 (2007) 458-466
6. Eliasson E., and Kenna J.G. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis. Mol. Pharmacol. 50 (1996) 573-582
7. Neve E.P., Eliasson E., Pronzato M.A., Albano E., Marinari U., and Ingelman-Sundberg M. Enzyme-specific transport of rat liver cytochrome P450 to the Golgi apparatus. Arch. Biochem. Biophys. 333 (1996) 459-465
8. Neve E.P., and Ingelman-Sundberg M. Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane. J. Biol. Chem. 275 (2000) 17130-17135
9. Cotman M., Jezek D., Fon Tacer K., Frangez R., and Rozman D. A functional cytochrome P450 lanosterol 14 alpha-demethylase CYP51 enzyme in the acrosome: transport through the Golgi and synthesis of meiosis-activating sterols. Endocrinology 145 (2004) 1419-1426
10. Yamamoto A.M., Mura C., De Lemos-Chiarandini C., Krishnamoorthy R., and Alvarez F. Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Clin. Exp. Immunol. 92 (1993) 381-390
11. Riley R.J., Smith G., Wolf C.R., Cook V.A., and Leeder J.S. Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s). Biochem. Biophys. Res. Commun. 191 (1993) 32-40
12. Ross Jr. W.T., and Cardell Jr. R.R. Proliferation of smooth endoplasmic reticulum and induction of microsomal drug-metabolizing enzymes after ether or halothane. Anesthesiology 48 (1978) 325-331
13. Ohkuma M., Park S.M., Zimmer T., Menzel R., Vogel F., Schunck W.H., Ohta A., and Takagi M. Proliferation of intracellular membrane structures upon homologous overproduction of cytochrome P-450 in Candida maltosa. Biochim. Biophys. Acta 1236 (1995) 163-169
14. Borlakoglu J.T., Edwards-Webb J.D., and Dils R.R. Polychlorinated biphenyls increase fatty acid desaturation in the proliferating endoplasmic reticulum of pigeon and rat livers. Eur. J. Biochem. 188 (1990) 327-332
15. Menzel R., Kargel E., Vogel F., Bottcher C., and Schunck W.H. Topogenesis of a microsomal cytochrome P450 and induction of endoplasmic reticulum membrane proliferation in Saccharomyces cerevisiae. Arch. Biochem. Biophys. 330 (1996) 97-109
16. Correia M.A., and Liao M. Cellular proteolytic systems in P450 degradation: evolutionary conservation from Saccharomyces cerevisiae to mammalian liver. Expert Opin. Drug Metab. Toxicol. 3 (2007) 33-49
17. Huan J.Y., Streicher J.M., Bleyle L.A., and Koop D.R. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. Toxicol. Appl. Pharmacol. 199 (2004) 332-343
18. Liao M., Faouzi S., Karyakin A., and Correia M.A. Endoplasmic reticulum-associated degradation of cytochrome P450 CYP3A4 in Saccharomyces cerevisiae: further characterization of cellular participants and structural determinants. Mol. Pharmacol. 69 (2006) 1897-1904
19. Kim P.S., and Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr. Rev. 19 (1998) 173-202
20. Brodsky J.L. The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). Biochem. J. 404 (2007) 353-363
21. Johnston J.A., Ward C.L., and Kopito R.R. Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143 (1998) 1883-1898
22. Kamhi-Nesher S., Shenkman M., Tolchinsky S., Fromm S.V., Ehrlich R., and Lederkremer G.Z. A novel quality control compartment derived from the endoplasmic reticulum. Mol. Biol. Cell 12 (2001) 1711-1723
23. Anelli T., and Sitia R. Protein quality control in the early secretory pathway. EMBO J. 27 (2008) 315-327
24. Huyer G., Longsworth G.L., Mason D.L., Mallampalli M.P., McCaffery J.M., Wright R.L., and Michaelis S. A striking quality control subcompartment in Saccharomyces cerevisiae: the endoplasmic reticulum-associated compartment. Mol. Biol. Cell 15 (2004) 908-921
25. Zuber C., Cormier J.H., Guhl B., Santimaria R., Hebert D.N., and Roth J. EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4407-4412
26. Vashist S., Kim W., Belden W.J., Spear E.D., Barlowe C., and Ng D.T. Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J. Cell Biol. 155 (2001) 355-368
27. Vashist S., and Ng D.T. Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J. Cell Biol. 165 (2004) 41-52
28. Kincaid M.M., and Cooper A.A. Misfolded proteins traffic from the endoplasmic reticulum (ER) due to ER export signals. Mol. Biol. Cell. 18 (2007) 455-463
29. Nakatsukasa K., Huyer G., Michaelis S., and Brodsky J.L. Dissecting the ER-associated degradation of a misfolded polytopic membrane protein. Cell 132 (2008) 101-112
30. Ramos R.R., Swanson A.J., and Bass J. Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 10470-10475
31. Szczesna-Skorupa E., and Kemper B. BAP31 is involved in the retention of cytochrome P450 2C2 in the endoplasmic reticulum. J. Biol. Chem. 281 (2006) 4142-4148
32. Szczesna-Skorupa E., Chen C.D., Rogers S., and Kemper B. Mobility of cytochrome P450 in the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14793-14798
33. Szczesna-Skorupa E., and Kemper B. Endoplasmic reticulum retention determinants in the transmembrane and linker domains of cytochrome P450 2C1. J. Biol. Chem. 275 (2000) 19409-19415
34. Szczesna-Skorupa E., Mallah B., and Kemper B. Fluorescence resonance energy transfer analysis of cytochromes P450 2C2 and 2E1 molecular interactions in living cells. J. Biol. Chem. 278 (2003) 31269-31276
35. Ozalp C., Szczesna-Skorupa E., and Kemper B. Bimolecular fluorescence complementation analysis of cytochrome p450 2c2, 2e1, and NADPH-cytochrome p450 reductase molecular interactions in living cells. Drug Metab. Dispos. 33 (2005) 1382-1390
36. Szczesna-Skorupa E., and Kemper B. The juxtamembrane sequence of cytochrome P-450 2C1 contains an endoplasmic reticulum retention signal. J. Biol. Chem. 276 (2001) 45009-45014
37. Szczesna-Skorupa E., and Kemper B. An N-terminal glycosylation signal on cytochrome P450 is restricted to the endoplasmic reticulum in a luminal orientation. J. Biol. Chem. 268 (1993) 1757-1762
38. Ahn K., Szczesna-Skorupa E., and Kemper B. The amino-terminal 29 amino acids of cytochrome P450 2C1 are sufficient for retention in the endoplasmic reticulum. J. Biol. Chem. 268 (1993) 18726-18733
39. Roberts B.J. Evidence of proteasome-mediated cytochrome P-450 degradation. J. Biol. Chem. 272 (1997) 9771-9778
40. Carvalho P., Goder V., and Rapoport T.A. Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126 (2006) 361-373
41. Szczesna-Skorupa E., Chen C.D., Liu H., and Kemper B. Gene expression changes associated with the endoplasmic reticulum stress response induced by microsomal cytochrome p450 overproduction. J. Biol. Chem. 279 (2004) 13953-13961
42. Lippincott-Schwartz J., Cole N.B., Marotta A., Conrad P.A., and Bloom G.S. Kinesin is the motor for microtubule-mediated Golgi-to-ER membrane traffic. J. Cell Biol. 128 (1995) 293-306
43. Lane J.D., Allan V.J., and Woodman P.G. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell. Sci. 118 (2005) 4059-4071
44. Franz S., Herrmann K., Fuhrnrohr B., Sheriff A., Frey B., Gaipl U.S., Voll R.E., Kalden J.R., Jack H.M., and Herrmann M. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ. 14 (2007) 733-742
45. Kochi S.K., and Collier R.J. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis. Exp. Cell Res. 208 (1993) 296-302
46. Mimnaugh E.G., Xu W., Vos M., Yuan X., Isaacs J.S., Bisht K.S., Gius D., and Neckers L. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol. Cancer. Ther. 3 (2004) 551-566
47. Mimnaugh E.G., Xu W., Vos M., Yuan X., and Neckers L. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol. Cancer. Res. 4 (2006) 667-681
48. Okiyoneda T., Harada K., Takeya M., Yamahira K., Wada I., Shuto T., Suico M.A., Hashimoto Y., and Kai H. Delta F508 CFTR pool in the endoplasmic reticulum is increased by calnexin overexpression. Mol. Biol. Cell 15 (2004) 563-574
49. Ferreira T., Mason A.B., Pypaert M., Allen K.E., and Slayman C.W. Quality control in the yeast secretory pathway: a misfolded PMA1 H+-ATPase reveals two checkpoints. J. Biol. Chem. 277 (2002) 21027-21040
50. Loeper J., Louerat-Oriou B., Duport C., and Pompon D. Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent. Mol. Pharmacol. 54 (1998) 8-13
51. Loeper J., Le Berre A., and Pompon D. Topology inversion of CYP2D6 in the endoplasmic reticulum is not required for plasma membrane transport. Mol. Pharmacol. 53 (1998) 408-414
52. Pagant S., Kung L., Dorrington M., Lee M.C., and Miller E.A. Inhibiting endoplasmic reticulum (ER)-associated degradation of misfolded Yor1p does not permit ER export despite the presence of a diacidic sorting signal. Mol. Biol. Cell. 18 (2007) 3398-3413
53. Mancias J.D., and Goldberg J. Exiting the endoplasmic reticulum. Traffic 6 (2005) 278-285
54. Annaert W.G., Becker B., Kistner U., Reth M., and Jahn R. Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J. Cell Biol. 139 (1997) 1397-1410
55. Schamel W.W., Kuppig S., Becker B., Gimborn K., Hauri H.P., and Reth M. A high-molecular-weight complex of membrane proteins BAP29/BAP31 is involved in the retention of membrane-bound IgD in the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9861-9866
56. Zen K., Utech M., Liu Y., Soto I., Nusrat A., and Parkos C.A. Association of BAP31 with CD11b/CD18. Potential role in intracellular trafficking of CD11b/CD18 in neutrophils. J. Biol. Chem. 279 (2004) 44924-44930
57. Wakana Y., Takai S., Nakajima K.I., Tani K., Yamamoto A., Watson P., Stephens D.J., Hauri H.P., and Tagaya M. Bap31 is an itinerant protein that moves between the peripheral ER and a juxtanuclear compartment related to ER-associated degradation. Mol. Biol. Cell. (2008)
58. Wang B., Heath-Engel H., Zhang D., Nguyen N., Thomas D.Y., Hanrahan J.W., and Shore G.C. BAP31 interacts with Sec61 translocons and promotes retrotranslocation of CFTRΔF508 via the derlin-1 complex. Cell 133 (2008) 1080-1092
59. Okazaki Y., Ohno H., Takase K., Ochiai T., and Saito T. Cell surface expression of calnexin, a molecular chaperone in the endoplasmic reticulum. J. Biol. Chem. 275 (2000) 35751-35758
60. Hoppe T., Matuschewski K., Rape M., Schlenker S., Ulrich H.D., and Jentsch S. Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell 102 (2000) 577-586
61. Braun S., Matuschewski K., Rape M., Thoms S., and Jentsch S. Role of the ubiquitin-selective CDC48(UFD1/NPL4 ) chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J. 21 (2002) 615-621
62. Vik A., and Rine J. Membrane biology: membrane-regulated transcription. Curr. Biol. 10 (2000) R869-R871
63. Black V.H., Barilla J.R., Russo J.J., and Martin K.O. A cytochrome P450 immunochemically related to P450c,d (P450I) localized to the smooth microsomes and inner zone of the guinea pig adrenal. Endocrinology 124 (1989) 2480-2493